Is it effective to take ginsenoside RH2 on the cervix?

The standard treatment for patients with advanced cervical cancer is still surgical treatment (conization biopsy, hysterectomy), and intracavitary radiotherapy can still be considered for patients who are not suitable for surgery. Patients with stage B~ who can undergo radical hysterectomy and pelvic lymph node metastasis, have positive surgical margins, or have parametrial residual tumors often have a poor prognosis. Platinum-based adjuvant chemotherapy/radiotherapy may help improve the prognosis of these patients. Stage B~ patients with larger tumors are currently also given concurrent chemotherapy/radiotherapy. The current radical treatment method for patients with locally advanced disease (B~) is the simultaneous application of platinum-based chemotherapy and radiotherapy.
Synchronized/radiotherapy or radical surgery (pelvic evisceration) can benefit patients with local recurrence and no distant metastasis. For patients with advanced stage (stage B) and patients with persistent or recurrent tumors, cisplatin alone or in combination with other active drugs (such as ifosfamide, paclitaxel, gemcitabine, camptothecin, norvinblastine) can be used as a palliative treatment. The basis of chemotherapy, but the standard protocol of palliative chemotherapy is currently uncertain.
Cervical adenocarcinoma has a worse prognosis than cervical squamous cell carcinoma. Adenocarcinomas are insensitive to radiation and most cytostatic drugs, and even in very early stages, there may be a tendency for lymphatic dissemination.
The treatment process of a cervical cancer patient
Ms. Huang, this year, works in Hangzhou City, Zhejiang Province. Diagnosed with cervical cancer. According to the doctor's treatment plan, I quickly underwent surgery and had a hysterectomy. However, in March 2016, cervical cancer was diagnosed with lymph node metastasis. The pathological examination revealed a moderately differentiated squamous cell carcinoma of the cervix, infiltrating into the deep stroma, involving the cervical dome and bilateral parauterine vessels, and showing tumor thrombus. A large number of tumor emboli were found in the full-thickness vessels of the cervical wall, and surrounding lymph nodes metastasized.
Ms. Huang started receiving chemotherapy. During chemotherapy, I suffered severe hair loss and often had stomachaches. Through many inquiries, his relatives and friends learned that ginsenoside R was effective in relieving the toxic side effects of chemotherapy, so they bought two boxes and started taking it. After the first chemotherapy, there are more white blood cells and fewer side effects of chemotherapy. This gives the patient a lot of peace of mind and confidence in the treatment. So I bought it again and kept taking it. Now I am taking more. Before the second chemotherapy, all the physical examination indicators were normal. Especially the very important indicator in the blood test, which used to be ./ (the normal value was less than ./), this time the test was also normal and was ./. After seeing the examination results, the patient felt relieved and hoped to successfully complete the subsequent treatment. In the past, the patient felt pain all over his body when walking, but now he walks slowly and does light activities without any problems.
After the second round of chemotherapy, the patient’s reexamination indicators were normal: .n/, .n/, for ./. The discharge record stated that there was no fever, chills, obvious fatigue, abdominal pain, diarrhea and other discomforts. His condition is stable and he is now requesting to be discharged from the hospital.
Therapeutic effect and improvement of quality of life
Description of some cases of Ms. Huang's chemotherapy and taking ginsenoside R
Note: The patient's appetite, energy, and sleep were okay, and there was no obvious change in urine and feces.
Note: After today’s chemotherapy, the patient’s condition is generally good, with no nausea, vomiting, abdominal pain, diarrhea, chest tightness, palpitations, dizziness, headache, normal urine output, and no abnormal sensation in the extremities. Physical examination: body temperature was normal, heart and lung auscultation were unremarkable, the abdomen was flat and soft, and the liver and spleen were not under the ribs. Blood routine and biochemical routine were basically normal.
Note: White blood cells (normal), neutrophil count (normal), monocyte count (normal), except lymphocytes (.<.) which are slightly lower than normal, other major immune cells The indicators are all normal.
Note: The chemotherapy process went smoothly, and the patient has no nausea, vomiting, abdominal pain or diarrhea. The vital signs were stable, no pathological murmur was heard during heart auscultation, the abdomen was flat and soft, no tenderness, and no abnormal masses were detected.